Health Canada Warns
Canadians Not to Use 'Sesa Hair Supplement'
July 25, 2004
Health Canada is warning consumers not to use “Sesa Hair Supplement”
capsules, a product designed to treat hair loss. This product is
contaminated with unacceptable levels of lead and could cause serious
adverse effects, including death. Health Canada strongly advises anyone who
has used Sesa Hair Supplement capsules to consult their physician.
Sesa Hair Supplement is manufactured by Rani-Pharma Inc. but may also be
sold by herbalists and acupuncturists without the name Rani-Pharma Inc on
the label. The Sesa Hair Supplement contains the following ingredients:
Mukta Sukti 100 mg, Sudha Shilajeet 100 mg, Rohitak 60 mg, Sudh Bodar 50 mg
and Rasayana 90 mg. The label directs that the product be taken with milk.
Health Canada assessed Sesa Hair Supplement capsules after receiving a
report that one patient taking the product required hospitalization due to
lead poisoning. The assessment found the capsules contain more than 7,000
times the allowable limit of lead in a health product. The product was also
found to contain mercury and arsenic.
Common symptoms of lead poisoning include: anemia, abdominal pain,
convulsions, coma or severe lack of coordination, and paralysis. Exposure to
high levels of lead can lead to damage to the intestines, blood system,
cardiovascular system, immune system, reproductive system, and kidneys.
Children are more sensitive to lead exposure than adults.
Health Canada has issued a stop sale order to clinics that stock this
product and has also issued a Customs Alert to prevent shipments of this
product from entering the country. Health Canada has also requested that
Rani-Pharma Inc. recall all existing product. This product has not been
authorized for use by Health Canada, and does not have a Drug Identification
Number (DIN) or Natural Product Number (NPN) or Drug Identification Number -
Homeopathic Medication (DIN-HM). Health Canada advises Canadians only to use
health products which carry a DIN, NPN or DIN-HM on the label.
Consumers and health care professionals are urged to report adverse
reactions to Health Canada by toll-free telephone at (866) 234-2345 or by
toll-free fax at (866) 678-6789.